πŸ‡ΊπŸ‡Έ FDA
Patent

US 11491237

Cyclodextrin protein drug conjugates

granted A61KA61K31/573A61K31/724

Quick answer

US patent 11491237 (Cyclodextrin protein drug conjugates) held by REGENERON PHARMACEUTICALS, INC. expires Mon Nov 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REGENERON PHARMACEUTICALS, INC.
Grant date
Tue Nov 08 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
59
CPC classes
A61K, A61K31/573, A61K31/724, A61K47/61, A61K47/6803